Selective inhibition of HDAC6 sensitizes cutaneous T‑cell lymphoma to PI3K inhibitors
Affiliations: Department of Immunology, Medical University of Warsaw, 02‑097 Warsaw, Poland, Department of Dermatology, University Hospital Zürich, University of Zurich, 8091 Zurich, Switzerland, Postgraduate School of Molecular Medicine, Medical University of Warsaw, 02‑097 Warsaw, Poland
- Published online on: May 6, 2020 https://doi.org/10.3892/ol.2020.11587
- Pages: 533-540
Copyright: © Bobrowicz et al. This is an open access article distributed under the terms of Creative Commons Attribution License.